Skip to main content

[vc_row][vc_column][vc_single_image image="40066" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into...

[vc_row][vc_column][vc_column_text] On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the same concept, based largely on commonly observed symptoms, that the virus targets...

[vc_row][vc_column][vc_column_text] Note: This is part two of Dr. Michael Wang's series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. In addition to surgery, radiation therapy and chemotherapy are the other two major medical procedures to treat brain cancers. Patients...